摘要
背景: 我们最近报道了表皮生长因子(EGF)通过激活p44/p42有丝分裂原激活蛋白(map)激酶、p38 map激酶、应激激活蛋白激酶/c-jun N末端激酶(SAPK/JNK)和Akt诱导成骨细胞样MC3T3-E1细胞的迁移。此外,我们证明热休克蛋白70(HSP70)通过抑制成骨细胞样MC3T3-E1细胞中p38- MAP激酶下调转化生长因子β刺激的血管内皮生长因子合成。然而,HSP70在成骨细胞迁移中的确切作用尚未完全阐明。 目的: 本研究旨在探讨热休克蛋白70抑制剂对表皮生长因子刺激的成骨细胞迁移的影响及其机制。 方法: 用两种类型的HSP70抑制剂(VER-155008或YM-08)治疗成骨细胞样MC3T3-E1细胞。对成骨细胞迁移进行了穿孔细胞迁移分析和伤口愈合分析。通过Western blot分析评价HSP70的表达水平和p38 MAP激酶、p44/p42 MAP激酶、SAPK/JNK或Akt的磷酸化。 结果: 在目前或不存在VER -155008的情况下,表皮生长因子几乎不影响hsp70的表达水平。通过跨井细胞迁移分析,HSP70抑制剂VER -155008和YM-08均能显著降低EGF刺激的迁移。通过伤口愈合实验,观察了两种热休克蛋白70抑制剂对表皮生长因子刺激的迁移的抑制作用。Ver-155008抑制了表皮生长因子诱导的p44/p42- MAP激酶和Akt的磷酸化,而不是p38- MAP激酶或SAPK/JNK。 结论: 这项研究提供了新的证据,证明HSP70抑制剂通过抑制p44/p42 MAP激酶和Akt减少了EGF刺激的成骨细胞迁移。
关键词: HSP70,EGF,迁移,p44/p42 MAP激酶,Akt,成骨细胞。
Current Molecular Medicine
Title:HSP70 Inhibitors Reduce The Osteoblast Migration By Epidermal Growth Factor
Volume: 18 Issue: 7
关键词: HSP70,EGF,迁移,p44/p42 MAP激酶,Akt,成骨细胞。
摘要: Background: We have recently reported that epidermal growth factor (EGF) induces migration of osteoblast-like MC3T3-E1 cells through the activation of p44/p42 mitogen-activated protein (MAP) kinase, p38 MAP kinase, stress-activated protein kinase/ c-Jun N-terminal kinase (SAPK/JNK) and Akt. Furthermore, we demonstrated that heat shock protein 70 (HSP70) down-regulates the transforming growth factor-β- stimulated vascular endothelial growth factor synthesis via suppression of p38 MAP kinase in osteoblast-like MC3T3-E1 cells. However, the exact role of HSP70 underlying osteoblast migration is not fully elucidated.
Objective: The aim of this study is to investigate the effects of HSP70 inhibitors on the EGF-stimulated osteoblast migration, and the underlying mechanism.
Methods: Osteoblast-like MC3T3-E1 cells were treated with two types of HSP70 inhibitors, VER-155008 or YM-08. Transwell cell migration assay and wound-healing assay were analyzed for osteoblast migration. The expression levels of HSP70 and the phosphorylation of p38 MAP kinase, p44/p42 MAP kinase, SAPK/JNK or Akt were evaluated by a Western blot analysis.
Results: EGF hardly affected the expression levels of HSP70 at the present or absent of VER-155008. EGF-stimulated migration was significantly reduced by both HSP70 inhibitors, VER-155008 and YM-08, determined by a transwell cell migration assay. The suppressive effects of both HSP70 inhibitors on the migration stimulated by EGF were also observed by a wound-healing assay. VER-155008 inhibited the EGF-induced phosphorylation of p44/p42 MAP kinase and AKT, but not p38 MAP kinase or SAPK/JNK.
Conclusion: This study provides new evidence that HSP70 inhibitors reduce the EGFstimulated migration of osteoblasts through the suppression of p44/p42 MAP kinase and Akt.
Export Options
About this article
Cite this article as:
HSP70 Inhibitors Reduce The Osteoblast Migration By Epidermal Growth Factor, Current Molecular Medicine 2018; 18 (7) . https://dx.doi.org/10.2174/1566524019666181213112847
DOI https://dx.doi.org/10.2174/1566524019666181213112847 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib
Anti-Cancer Agents in Medicinal Chemistry Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women
Current Medicinal Chemistry Mechanisms of Incretin Effects on Plasma Lipids and Implications for the Cardiovascular System
Cardiovascular & Hematological Agents in Medicinal Chemistry Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Interstitial Lung Disease in Sjogrens Syndrome
Current Rheumatology Reviews Autonomic Nervous System Dysfunction in Sjogrens Syndrome
Current Rheumatology Reviews Association of Large Vessel Aneurysm/Pseudo-Aneurysm/Aortitis and Deep Vein Thrombosis in Patients with Behçet’s Disease: A Case Report
Current Rheumatology Reviews Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes
Drug Metabolism Letters Hypertension in Hemodialysis Patients
Current Hypertension Reviews Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Selenium and Autoimmune Diseases: A Review Article
Current Rheumatology Reviews Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
Current Pharmaceutical Biotechnology Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Current Pharmaceutical Design Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued)